Hamish Chamberlayne, Portfolio Manager of the Global Sustainable Equity Strategy, discusses how these interlinked themes are penetrating every sector of the economy.
Andy Acker, Ethan Lovell and Rich Carney of the Global Life Sciences Team discuss key trends for investors to consider as the drug pricing debate heats up.
Research analysts Ian McDonald and Tom Delong discuss the disruptive nature of blockchains and how companies can leverage the technology to gain efficiencies.
Hamish Chamberlayne, Portfolio Manager for the Global Sustainable Equity Strategy, discusses the momentum in clean tech.
Like retailers, banks are moving from brick-and-mortar networks to digital experience as in-app transactions increasingly usurp in-branch visits.
Lead Energy Analyst Noah Barrett sees interest rising in select, high-quality, oil-related stocks after Brent crude reached $80 for the first time since 2014.
Ethan Lovell outlines the possible impacts of President Trump’s desire to make the U.S. drug market more competitive, especially in relation to government-funded programs.
After attending a conference on disruptive tech, Portfolio Manager Rebecca Young discusses startups and why bond managers should be aware of the evolving risks.
Our experts discuss the questions investors should be asking as global life expectancy continues to rise.
Portfolio Manager Brad Slingerlend shares why when it comes to technology, savvy investors appreciate that AI means more than just artificial intelligence.
Portfolio Managers Brad Slingerlend and Denny Fish explain how strong fundamentals should help tech sector leaders withstand bouts of volatility.
Portfolio Manager Doug Rao shares why he believes semiconductor content in autos may grow at a double-digit rate over the next decade.